Characterization of Endogenous G-CSF and the Inverse Correlation to Chemotherapy-Induced Neutropenia in Patients with Breast Cancer Using Population Modeling

Model-Based Approach to Describe G-CSF Effects in Carboplatin-Treated Cancer Patients

(2013) Mélanie L. Pastor et al.   PHARMACEUTICAL RESEARCH

Comparison of different semi-mechanistic models for chemotherapy-related neutropenia: application to BI 2536 a Plk-1 inhibitor

(2011) Elena Soto et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Prediction of Neutropenia-Related Effects of a New Combination Therapy With the Anticancer Drugs BI 2536 (a Plk1 Inhibitor) and Pemetrexed

(2010) E Soto et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A simultaneous analysis of the time-course of leukocytes and neutrophils following docetaxel administration using a semi-mechanistic myelosuppression model

(2010) Angelica Linnea Quartino et al.   INVESTIGATIONAL NEW DRUGS

Population Modeling of Filgrastim PK-PD in Healthy Adults Following Intravenous and Subcutaneous Administrations

(2010) Wojciech Krzyzanski et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Model-Based Neutrophil-Guided Dose Adaptation in Chemotherapy: Evaluation of Predicted Outcome with Different Types and Amounts of Information

(2009) Johan E. Wallin et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Limited inter-occasion variability in relation to inter-individual variability in chemotherapy-induced myelosuppression

(2009) Emma K. Hansson et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Population Pharmacokinetic Modelling of Filgrastim in Healthy Adults following Intravenous and Subcutaneous Administrations

(2009) Pawel Wiczling et al.   CLINICAL PHARMACOKINETICS